Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
461
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+393K
-
Total reported value, excl. options
-
$8.67B
-
Value change
-
+$211M
-
Put/Call ratio
-
0.93
-
Number of buys
-
256
-
Number of sells
-
-188
-
Price
-
$451.49
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2020
509 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q2 2020.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 461 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.31M shares), BlackRock Inc. (1.58M shares), STATE STREET CORP (927K shares), FMR LLC (816K shares), AMERICAN CENTURY COMPANIES INC (664K shares), WELLS FARGO & COMPANY/MN (529K shares), ATLANTA CAPITAL MANAGEMENT CO L L C (452K shares), BROWN ADVISORY INC (415K shares), UBS ASSET MANAGEMENT AMERICAS INC (413K shares), and ALLIANCEBERNSTEIN L.P. (401K shares).
This table shows the top 461 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.